ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1973

Giant Cell Arteritis and Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis

Patompong Ungprasert1, Narat Srivali2 and Wonngarm Kittanamongkolchai3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 3Nephrology and hypertension, Mayo Clinic, Rochester, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: giant cell arteritis and meta-analysis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Giant
Cell Arteritis and
Risk of Cerebrovascular Accident: A
Systematic Review and Meta-analysis

Background/Purpose: Several chronic inflammatory
disorders, such as systemic lupus erythematosus and psoriatic
arthritis, have been linked to an increased risk of cerebrovascular
accident (CVA).  However, the data on giant cell arteritis (GCA), one of
the most common systemic vasculitides in older adults, are
unclear as epidemiologic studies yielded inconsistent results.  Thus, to
further investigate this association, we conducted a systematic review and
meta-analysis of observational studies that compared the risk of
CVA in patients with GCA versus participants without it.

Methods: Two investigators independently searched
published studies indexed in MEDLINE, EMBASE and the Cochrane database from
inception to April 2015 using the terms “giant cell arteritis” and “temporal
arteritis” combined with the terms for cerebrovascular accident.  A
manual search of references of selected articles was also performed.  The
inclusion criteria were as follows: (1) cohort or case-control study evaluating
the association between GCA and CVA (2) odds ratio (OR),
relative risk (RR) or hazard ratio (HR) or standardized incidence ratio (SIR)
with 95% confidence interval (CI) were provided.  Study
eligibility was independently determined by the two investigators. 
Newcastle-Ottawa scale was used to assess the quality of the included studies.

Point estimates and standard errors were extracted from
individual studies and were combined by the generic inverse variance method of
DerSimonian and Laird.  In light of the high likelihood of between study
variance, we used a random-effect model rather than a fixed-effect model. 
Statistical heterogeneity was assessed using the Cochran’s Q test.  This
statistical analysis was performed using RevMan 5.3 software.  

Results: Out of 713 potentially relevant articles,
five studies (three retrospective cohort studies, one prospective study and one
case-control study) were identified and included in our data analysis.
 The pooled risk ratio of CVA in patients with GCA was 1.29 (95% CI, 1.17
to 1.42). The statistical heterogeneity of this meta-analysis was insignificant
with an I2 of 0%.

Conclusion: Our study demonstrated a significantly increased
CVA risk among patients with GCA with 29% excess risk
compared with general population.


Disclosure: P. Ungprasert, None; N. Srivali, None; W. Kittanamongkolchai, None.

To cite this abstract in AMA style:

Ungprasert P, Srivali N, Kittanamongkolchai W. Giant Cell Arteritis and Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/giant-cell-arteritis-and-risk-of-cerebrovascular-accident-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/giant-cell-arteritis-and-risk-of-cerebrovascular-accident-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology